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activation of this enzyme with a decreasing order of activity:Activation of PLC and PI 3 kinase by PDGF receptor a is
BB . AB . AA.not sufficient for mitogenesis and migration in mesangial cells.
Conclusion. Taken together, these data demonstrate that allBackground. Platelet-derived growth factor (PDGF) iso-
three isoforms of PDGF significantly stimulate PLCg1 and PIforms act through two distinct cell surface a and b receptors.
3 kinase, two enzymes necessary for both DNA synthesis andGlomerular mesangial cells express both receptors. PDGF BB
directed migration. However, activation of a receptor by PDGFand AB are potent mitogens for glomerular mesangial cells, and
AA with a subsequent increase in PLC and PI 3 kinase activitiesPDGF BB stimulates cell migration in a phosphatidylinositol 3
is not sufficient to induce these biological responses in mesan-(PI 3) kinase-dependent manner. In this study, we investigated
gial cells. These data indicate that the extent of activation ofthe effect of PDGF AA on cell migration, PI 3 kinase and
signal transduction pathways may be a major determinant ofphospholipase C (PLC) activation, and the role of these two
enzymes in mediating biological responses in these cells in the biological activity of different PDGF isoforms in mesangial
response to all three isoforms. cells.
Methods. 3H-thymidine incorporation and modified Boyden
chamber assay were used to determine DNA synthesis and
directed migration, respectively, in response to all three PDGF
Platelet-derived growth factor (PDGF) stimulatesisoforms. Differential activation of a and b receptors was stud-
growth and chemotaxis of many mesenchymal cells, in-ied by immunecomplex tyrosine kinase assay of corresponding
receptor immunoprecipitates. PLCg1 activity was determined cluding glomerular mesangial cells. Two different struc-
by measuring total inositol phosphates in response to different turally similar chains of PDGF (A and B chains) assem-
PDGF isoforms. PI 3 kinase activity was determined in anti- ble into three different isoforms of PDGF as AA andphosphotyrosine or PDGF receptor immunoprecipitates.
BB homodimers and AB heterodimer [1]. In spite of theResults. Both PDGF BB and AB resulted in stimulation of
high sequence identity between the two PDGF subunits,DNA synthesis and directed migration of mesangial cells. AA
was neither chemotactic nor mitogenic. However, all three each subunit serves a specific function during develop-
isoforms increased tyrosine phosphorylation of a 180 kD pro- ment and in the adult [1, 2]. Thus, inactivation of PDGF
tein in antiphosphotyrosine immunoprecipitates, suggesting ac- A chain results in generalized lung emphysema causedtivation of respective receptors. Direct immunecomplex tyro-
by a lack of alveolar myofibroblasts [3]. PDGF B chain-sine kinase assay of a and b receptors demonstrated significant
deficient mice show a complete loss of glomerular mesan-activation of both of these receptors when cells are treated
with PDGF BB or AB. PDGF AA increased tyrosine kinase gial cells [4]. In the adult animal, PDGF B chain is over-
activity of the a receptor but not the b receptor. All three expressed in association with inflammatory and prolifer-
isoforms significantly stimulated the production of inositol ative glomerular diseases [5, 6].phosphates with order of potency being BB . AB . AA.
Two structurally similar transmembrane PDGF recep-PDGF AA also dose dependently stimulated PI 3 kinase activ-
tors (PDGFR) with intrinsic tyrosine kinase activity haveity measured in antiphosphotyrosine immunoprecipitates of
treated cells. A comparison of PI 3 kinase activity in antiphos- been identified [7–10]. The a receptor binds both A and
photyrosine immunoprecipitates from mesangial cells stimu- B chains of PDGF, whereas the b receptor binds only
lated with three different PDGF isoforms showed significant the B chain. Although both receptors stimulate mitogen-
esis in target cells, they often differ in eliciting many
other biological activities [11]. The intracellular segmentKey words: PDGF receptors, cell signaling, DNA synthesis, tyrosine
kinase, enzymatic pathway, chemotactic response. of the receptors contain two tyrosine kinase domains
separated by a stretch of amino acids known as kinaseReceived for publication February 17, 1999
insert domain. Binding of the PDGF dimer to the extra-and in revised form September 2, 1999
Accepted for publication September 20, 1999 cellular domain induces receptor dimerization and trans-
phosphorylation of each subunit. This autophosphoryla-Ó 2000 by the International Society of Nephrology
908
Choudhury et al: PDGF receptors in mesangial cells 909
tion increases its intrinsic tyrosine kinase activity and (Kanukee, IL, USA). Protein measurement and poly-
provides docking sites for downstream signal transduc- acrylamide gel reagents were purchased from Bio-Rad
tion proteins. The autophosphorylation sites are exten- (Hercules, CA, USA). PDGF BB, AB, and AA were
sively analyzed in the b receptor. Out of 15 tyrosine provided by Amgen Inc. (Thousand Oaks, CA, USA).
residues in the noncatalytic part of the b receptor, 11 Agarose-conjugated antiphosphotyrosine antibody was
are phosphorylated in response to PDGF and 10 SH2 obtained from Oncogene Science (Cambridge, MA,
domain-containing signaling proteins interact directly or USA). Anti-PDGFR a- and b-monoclonal antibodies
indirectly with this receptor [12, 13]. Many of these tyro- were purchased from Genzyme (Boston, MA, USA).
sines serve as docking sites for different signaling mole- Polyclonal antibody against 85 kD regulatory subunit of
cules and are present in the homologous position in the PI 3 kinase was obtained from UBI (Lake Placid, NY,
a receptor, although all 10 signaling proteins known to
USA). Protein A sepharose CL 4B was obtained from
interact with b receptor have not been characterized with
Pharmacia LKB Biotechnology Inc. (Piscataway, NJ,respect to their interaction with a receptor. Activation of
USA).PDGFR initiates three major signal transduction cas-
cades that include activation of phosphatidylinositol 3
Human glomerular mesangial cell culture(PI 3) kinase, phospholipase g1 (PLCg1), and Ras-mito-
Detailed procedures for isolation and characterizationgen-activated protein kinase (MAPK) pathways [12–14].
of human mesangial cells were described previously [21–PI 3 kinase and PLCg1 interact with the homologous
24]. The cells represent a homogeneous population oftyrosine residues in the kinase insert domain and the
C-terminal tail of both receptors, respectively [15–17]. smooth muscle-like cells free of endothelial and epithe-
We have recently shown that PDGF BB stimulates PI lial cell contamination. Mesangial cells were grown in
3 kinase in these cells, and attenuation of its activity by Waymouth’s medium containing 17% fetal calf serum.
pharmacological inhibitors blocks DNA synthesis and The monolayers were washed with phosphate-buffered
migration of these cells [18–21]. We also previously re- saline three times and were incubated in serum-free me-
ported that these cells express both a and b receptors dium for 48 hours with a change of fresh serum-free
[22]. Initial studies using all three isoforms of PDGF medium at 24 and 36 hours to deplete secreted PDGF
demonstrated that PDGF BB is the most potent mitogen and to prevent down-regulation of the PDGFRa [22].
for these cells (BB . AB). In mesangial cells, the effect The cells were used between passages 5 and 9.
of PDGF AA on PI 3 kinase and cell migration and
systematic analysis of each receptor activation in re- Cell migration assay
sponse to all isoforms of PDGF, leading to signal trans-
Directed migration of mesangial cells was determinedduction pathways necessary for proliferation and migra-
using a modified method of Boyden chamber assay [20,tion of these cells, have not been performed. In this
25]. Briefly, confluent human mesangial cells were incu-study, we investigated the contribution of each PDGF
bated in serum-free Waymouth’s medium for 48 hoursisoform to activation of both a and b receptors. We
with a change of medium as described earlier in thisfound that PDGF AA stimulates the a-receptor–
associated tyrosine kinase activity, resulting in a signifi- article. The cells were trypsinized, washed with Hank’s
cant increase in the activity of PLCg1 and PI 3 kinase. solution without Ca21 and Mg21, and resuspended in
However, unlike PDGF BB and AB, the AA isoform serum-free medium in the presence of 1% human serum
does not induce chemotaxis or DNA synthesis in mesan- albumin in a 50 mL Falcon tube. To avoid attachment
gial cells. The extent of activation of these enzymatic of cells to the tube wall, it was kept on a rotating platform
pathways was less with PDGF AA than PDGF BB or until use. Different isoforms of PDGF were placed in the
AB. Our data suggest that PDGF AA-induced activation bottom chamber of Boyden apparatus. A polycarbonate
of PLCg1 and PI 3 kinase is not sufficient for the induc- membrane filter (14 mm pore size) coated with 0.02
tion of mitogenic or chemotactic responses in mesangial mg/mL collagen type I was placed in the middle of the
cells.
chamber. The mesangial cell suspension was placed in
the top chamber and incubated for eight hours at 378C.
METHODS The filter was then inverted on a glass cover slip, fixed
with methanol, and stained with Giemsa. The dried filterMaterials
was then mounted on a slide with Permount. The stainedTissue culture materials were purchased from GIBCO/
cells were counted in the center of each filter in 10 high-BRL (Rockville, MD, USA). Phosphatidylinositol (PI),
power fields (magnification 3450). Each assay was per-Nonidet P-40 (NP-40), phenylmethylsulfonyl fluoride
formed in triplicate. The data are presented as number(PMSF), and Na3VO4 were obtained from Sigma (St.
Louis, MO, USA). Aprotinin was purchased from Bayer of cells per high-power field.
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Measurement of DNA synthesis PDGF receptor a or b immunoprecipitates were resus-
pended in PI 3 kinase assay buffer [20 mmol/L Tris.HCl,DNA synthesis was measured as 3H-thymidine incor-
pH 7.5, 0.1 mol/L NaCl, and 0.5 mmol/L egtazic acidporation into trichloroacetic acid insoluble material as
(EGTA)]. One-half microliter of 20 mg/mL PI in DMSOdescribed previously [20, 22, 23].
was added. The mixture was incubated at 258C for 10
Immunoprecipitation and immune complex tyrosine minutes, and then 1 mL of 1 mol/L MgCl2 and 10 mCi
kinase assay of g32P-ATP were added simultaneously and incubated
at 258C for another 10 minutes. A mixture of CHCl3,Immunoprecipitation was carried out as described pre-
CH3OH, and 11.6 N HCl (50:100:1) was added to stopviously [26–29]. Briefly, control and PDGF-stimulated
the reaction. The reaction was then further extractedmesangial cells were lyzed in RIPA buffer [20 mmol/L
with chloroform. The organic layer was washed withTris-HCl, pH 7.5, 150 mmol/L NaCl, 5 mmol/L ethylene-
CH3OH and 1 N HCl (1:1). The final organic layer wasdiaminetetraacetic acid (EDTA), 1 mmol/L Na3VO4, 1%
dried under a stream of nitrogen and resuspended inNP-40, 1 mmol/L PMSF, and 0.1% aprotinin] at 48C for
CHCl3 and separated by thin-layer chromatography in30 minutes. The lyzed monolayer was scraped from
plates and centrifuged at 10,000 g for 30 minutes at 48C. CHCl3/CH3OH/28% NH4OH/H2O (129:114:15:21). The
The cleared supernatant was used to estimate protein separated radioactive spots were visualized by autoradi-
content using the Bio-Rad reagent. An equal amount ography.
(100 to 500 mg) of protein was incubated with appro-
Data analysispriate antibody for 30 minutes on ice. Protein A sepha-
rose beads were added, and the mixture was rotated in The significance of the data was determined by com-
48C for two hours. In the case of antiphosphotyrosine parison of multiple groups using analysis of variance
immunoprecipitates, agarose-conjugated antibody was (ANOVA).
incubated with the cell lysate. The beads were washed
three times with RIPA buffer, twice with 50 mmol/L
RESULTSTris-HCl, pH 7.4, 0.5 mmol/L Na3VO4. The immunopre-
Effect of PDGF isoforms on mesangial cell migrationcipitates were then used in an in vitro tyrosine kinase
assay, as described previously [26, 28, 29]. We have previously reported that PDGF BB and AB
are potent mitogens in cultured mesangial cells [22].Measurement of phospholipase C activity
However, AB was less potent than BB. In contrast, AA
The PLC activity was determined as a measure of isoform was not mitogenic. Binding analysis of three
total inositol phosphates production in cells as described different isoforms revealed the presence of appreciable
before [30]. Briefly, human mesangial cells in 12-well number of binding sites for all three PDGFs with BB .
dishes were incubated in inositol-free serum-free RPMI AB . AA. In addition to proliferation, mesangial cell
1640 medium containing 3 mCi/mL of myo-[2-3H]-inosi- migration is an important biological response during glo-
tol for 48 hours as described previously in this article. merular injury. We have recently shown that PDGF BB
The cells were washed with HEPES buffer containing stimulates directed migration of mesangial cells [19, 20].
1.3 mmol/L Ca21 and 7.5 mmol/L LiCl. The cells were
All three PDGF isoforms have been shown to stimulatethen incubated in the same buffer for 15 minutes before
chemotaxis in a cell-type–specific manner [31]. We testedstimulation with PDGF isoforms at 378C. The incubation
the effect of different PDGF isoforms on migration ofwas terminated by quickly aspirating the medium and
mesangial cells. The data show that both PDGF BB andadding 2 mL of ice-cold 5% trichloric acid (TCA). The
AB induced migration of the cells (Fig. 1A). The foldcells were then scraped, and each well was rinsed with
stimulation with BB was 9.5 as compared with 7 in theanother 2 mL of 5% TCA. The sample was then ex-
presence of AB. PDGF AA did not stimulate migrationtracted three times with diethylether. After neutraliza-
of mesangial cells. With the same mesangial cells used fortion, the samples were loaded onto 2 mL AG1 3 8 anion
the chemotaxis assay, we also repeated the 3H-thymidineexchange column. The column was washed with 10 mL
incorporation assay in the presence of three differentwater followed by 10 mL 5 mmol/L Na-tetraborate. The
isoforms of PDGF. We confirm that PDGF AA does notinositol mono-, bis-, and tris-phosphates were then
result in mitogenesis, whereas BB and AB significantlyeluted with 10 mL of increasing concentrations of ammo-
increased DNA synthesis in mesangial cells with a po-nium formate in 0.1 mol/L formic acid. Two milliliters
tency of BB . AB (Fig. 1B).of each collected fraction were mixed with scintillation
fluid and counted in a b counter.
Activation of a and b receptors in response to
different PDGF isoformsMeasurement of PI 3 kinase activity
Activated PDGFR is present as a signaling complexThe PI 3 kinase activity was determined as described
previously [20, 21, 26]. Briefly, antiphosphotyrosine or in PDGF-treated cells. However, all of the signaling pro-
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Fig. 2. Effect of PDGF isoforms on tyrosine kinase activity of proteins
in antiphosphotyrosine immunoprecipitates. Serum-deprived human
mesangial cells were treated with different PDGF isoforms, and cell
lysates were immunoprecipitated with 20 mL of 50% slurry of agarose-
conjugated antiphosphotyrosine antibody. The immunoprecipitates
were then used in an immunecomplex kinase assay in the presence of
g32P-ATP as described in the Methods section. Lane 3 represents the
untreated control. The arrow indicates tyrosine phosphorylated 180 kD
protein. The numbers in left margin represent the position of molecular
weight markers.
PDGF AB-, AA-, and BB-treated human mesangial cells
in the presence of g32P-ATP. The data show a major
tyrosine-phosphorylated protein migrating around 180
kD (Fig. 2, indicated by arrow). Based on apparent mo-
Fig. 1. Effect of three platelet-derived growth factor (PDGF) isoforms lecular weight, this protein likely represents activated
on migration and DNA synthesis. (A) Serum-deprived quiescent human PDGFR. Reduced mobility of this protein in AB-, AA-,
mesangial cells were used in cell migration assay in the presence of
and BB-treated cells compared with control cells (lane 3)PDGF AA, AB, and BB, respectively, as described in the Methods
section. The data represent mean 6 SEM of three independent experi- indicates its hyperphosphorylation in response to these
ments. *P , 0. 05 vs. untreated control. (B) 3H-thymidine incorporation growth factors. We should emphasize that tyrosine phos-
was measured as an index of DNA synthesis in response to three
phorylation of this protein is in a decreasing order withisoforms of PDGF. Results are mean 6 SE of four independent experi-
ments. *P , 0.05 vs. untreated control. BB . AB . AA. Overexposure of this gel showed other
tyrosine-phosphorylated proteins, although the pattern
is not identical with all three isoforms (data not shown).
To determine the contribution of each PDGF isoform
teins that associate directly or indirectly with the PDGFR to specific receptor activation, we performed im-
have not yet been identified, particularly proteins associ- munecomplex kinase assay of a and b receptors from
ated with and tyrosine phosphorylated by a-receptor. We lysates of mesangial cells treated with homodimers and
have reported earlier that because of a low abundance of heterodimers of PDGF. The results demonstrate the dif-
signaling proteins in human mesangial cells [28], anti- ferential activation of receptor subtypes in response to
phosphotyrosine immunoblot of PDGFR immunopre- each isoform (Fig. 3). The major phosphorylated protein
cipitates did not show any tyrosine-phosphorylated at 180 kD represents the autophosphorylated PDGFR
proteins. To detect proteins that are tyrosine phosphory- (indicated by arrow). In untreated cells, as expected,
lated, we performed immunecomplex kinase assay of b-receptor autophosphorylation is higher than that of the
a receptor (compare lane 2 with 1). PDGF BB stimulatesantiphosphotyrosine immunoprecipitates from lysates of
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Fig. 3. Effect of PDGF isoforms on a- and
b-receptor-associated tyrosine kinase activity.
Lysates of mesangial cells treated with three
different isoforms of PDGF were immunopre-
cipitated with 10 mg of monoclonal antibodies
against a or b receptor. The immunoprecipi-
tates were used in an immune complex kinase
assay, as described in the Methods section.
The arrow indicates the position of PDGF
receptor. The asterisk indicates 91 kD protein.
The numbers in the left margin indicate the
position of molecular weight markers.
both a and b receptors (compare lane 3 with 1 and
lane 4 with 2), although b-receptor activation is more
pronounced (lane 4). PDGF AB also activates both a
and b receptors (compare lanes 5 and 6 with lanes 1
and 2, respectively). a-Receptor activation was more
pronounced (compare lane 5 with 1) than b-receptor
(compare lane 6 with 2), although the extent of phos-
phorylation was similar (lanes 5 and 6). In contrast to
PDGF BB and AB, PDGF AA activates only the a
receptor (compare lane 7 with lane 1). Note that this
activation of a receptor is almost comparable to that of
b-receptor activation by PDGF BB (compare lane 7 with
lane 4). These data indicate that in mesangial cells, both
a and b receptors are activated by the cognate isoforms
of PDGF to a similar extent. One major phosphorylated
protein at 91 kD was identified in both b- and a-receptor
Fig. 4. Effect of PDGF isoforms on PLC activity. Quiescent mesangialimmunoprecipitates (Fig. 3, indicated by an asterisk).
cells were labeledwith 3H-myoinositol and were incubated with differentThis may represent STAT1a, which we have recently isoforms of PDGF. Total inositol phosphate production was determined
characterized as a direct target of PDGFRb in mesangial as described in the Methods section as a measure of PLC activity.
cells [28]. However, STAT1a gene disruption in mice
showed no abnormalities in PDGF-induced signal trans-
duction [32].
the experimental condition [23]. In this study, we made
Activation of PLC by PDGF isoforms frequent changes of serum-free medium during starva-
tion of human mesangial cells to deplete any accumu-Using PDGFR b mutant that is incapable of binding
lated growth factors and cytokines before the additionPLCg1, it has been reported that activation of this en-
of different PDGF isoforms (Methods section). Cellszyme is necessary for PDGF BB-induced DNA synthesis
were then labeled with 3H-inositol and stimulated with[15, 16]. We have previously shown that PDGF AB and
three different isoforms of PDGF. Total inositol phos-BB induce PI turnover in human mesangial cell. In that
phates were measured as an activity of PDGF-stimulatedstudy, we reported that AA does not stimulate inositol
PLC. The results show a significant increase in inositolphosphate production [22]. We have shown previously
phosphate production with all three PDGF isoforms withthat human mesangial cells constitutively express and
decreasing activity of BB . AB . AA (Fig. 4). Thesesecrete predominantly PDGF A chain, suggesting that
a receptors may be down-regulated in these cells under data indicate that PDGF AA is capable of activating
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Fig. 5. Effect of different dose of PDGF AA and AB on PI 3 kinase activity in human mesangial cells. Mesangial cells were incubated with a
different concentration of AA (A) and AB (B). The cleared lysates were immunoprecipitated with antiphosphotyrosine antibody as described in
Figure 2. The immunoprecipitates were assayed for PI 3 kinase activity as described in the Methods section. The arrow indicates the position of
PI 3-P spot.
PLC. However, the extent of activation is not sufficient Association of PI 3 kinase with platelet-derived
growth factor receptorto stimulate DNA synthesis and migration (Fig. 1).
We have previously shown that PI 3 kinase physically
Activation of PI 3 kinase by platelet-derived growth associates with tyrosine-phosphorylated PDGFR-b in
factor isoforms in mesangial cells mesangial cells [21]. However, the effect of different
PDGF isoforms on the association of PI 3 kinase withUsing mutational analysis of PDGFR, it was shown
the receptor in same cells had not been tested. To detectthat PI 3 kinase is necessary for PDGF-induced DNA
the association of proteins with PI 3 kinase in mesangialsynthesis [15]. The requirement of this enzyme is more
cells, cells were treated with different isoforms, and ly-tightly correlated with mitogenesis than other signaling
sates were immunoprecipitated with antibody against themolecules linked to PDGF function [15, 20]. Previously,
85 kD PI 3 kinase regulatory subunit. The immunopre-we showed dose-dependent activation of PI 3 kinase in
cipitates were used in an immunecomplex kinase assay.human mesangial cells with maximum activation at 10
The principle of this experiment is to assay the associatedng/mL of PDGF BB [21]. We have recently shown that
PDGFR, if any, with the PI 3 kinase subunit in theactivation of PI 3 kinase is obligatory for PDGF-induced
presence of PDGF. The results show association and
migration and DNA synthesis in mesangial cells [20]. increased tyrosine phosphorylation of 180 kD PDGFR
We now investigated the effect of PDGF AB and AA (Fig. 6, indicated by the star) in response to all three
on PI 3 kinase activity. Mesangial cells were incubated isoforms of PDGF. However, the extent of tyrosine phos-
with different concentrations of AA and AB. The lowest phorylation was significantly higher in cells treated with
dose used was 10 ng/mL because we previously showed BB compared with AB or AA (compare lane 4 with 2
that this concentration was optimum for PDGF BB [21]. or 3). Along with PDGFR phosphorylation, multiple
Antiphosphotyrosine immunoprecipitates of lysates of proteins are phosphorylated, one of which is the 85 kD
mesangial cells treated with PDGF isoforms were as- regulatory subunit of PI 3 kinase (indicated by the
sayed for PI 3 kinase activity. As shown in Figure 5, both arrow). These data indicate that PI 3 kinase is present
AA and AB stimulate PI 3 kinase activity in mesangial in a signaling complex in all three PDGF isoform-treated
cells. Ten ng/mL of each isoform are sufficient to activate mesangial cells.
To test directly the association of PI 3 kinase activityPI 3 kinase significantly.
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DISCUSSION
Accumulating evidence suggests that PDGF plays an
important role in inflammatory and proliferative glomer-
ular diseases [5, 6, 19]. Increased expression of PDGF
B chain and b receptor has been associated with experi-
mental models of glomerulonephritis [5, 6]. Previous
studies showed that in cultured mesangial cells, PDGF
BB and AB stimulate PLC and PLA2 activity with a
concomitant increase in intracellular Ca21 and activation
of Na1/H1 antiport, leading to alkalinization of the cyto-
plasm [33]. However, there is limited information on the
effect of PDGF AA on mesangial cells, and there are
no comparative studies on signal transduction pathways
with the three isoforms of PDGF in mesangial cells. OurFig. 6. Association of PI 3 kinase with PDGFRs. Quiescent mesangial
study demonstrates that PDGF BB and AB activate PLCcells were incubated with different PDGF isoforms. The cleared cell
lysates were immunoprecipitated with 5 mL of polyclonal antibody and PI 3 kinase and stimulate migration and DNA syn-
against the 85 kD regulatory subunit of PI 3 kinase. The immunoprecipi- thesis in mesangial cells. PDGF AA, on the other hand,tates were used in an in vitro immune complex kinase assay in the
while activating both enzymes fails to induce DNA syn-presence of g32P-ATP as described in the Methods section. The arrow
indicates a 85 kD regulatory subunit of PI 3 kinase. The star indicates thesis and cell migration.
tyrosine-phosphorylated PDGFR. The molecular weight markers are
The lack of effect of PDGF AA on DNA synthesisshown in the left margin.
and migration may be the result of a lower number of
binding sites for this homodimer on mesangial cells com-
pared with BB and AB [22]. However, in normal rat
kidney cells, binding of all three isoforms demonstratedwith different PDGFR subunits, we immunoprecipitated
similar results as mesangial cells in that it binds BB .b receptor from mesangial cells incubated with AB and
AB . AA [34]. In these cells, PDGF AA is as potent asa receptor from AA-treated cells. PI 3 kinase activity
BB in inducing anchorage-independent growth. Similarwas determined in these immunoprecipitates. The results
results were obtained with cultured smooth muscle cellsshow association of PI 3 kinase with both b and a recep-
that showed similar magnitude of replicative responsetor in response to AB and AA, respectively (Fig. 7).
in spite of the order of potency of binding BB . AB .These data indicate that similar to b receptor, the a
AA [35]. These observations indicate that lower numberreceptor interacts with PI 3 kinase in mesangial cells.
of a receptors cannot explain the decreased proliferative
response. In contrast, the strength of activated signalingDifferential activation of PI 3 kinase by three
molecules induced by AA in these cells may be sufficientPDGF isoforms
to induce comparable mitogenic response as inducedWe and others have established that PI 3 kinase is
by BB.associated with tyrosine phosphorylated PDGFR [13,
It is well established that activation of PLCg1 is neces-15, 20, 21]. Therefore, the use of antiphosphotyrosine
sary for PDGF-induced DNA synthesis and migration
antibody to immunoprecipitate total tyrosine phosphor-
[15, 36, 37]. This signal-transducing protein physically
ylated proteins from PDGF-treated cells will include interacts with both a and b receptors via the SH2 domain.
PDGFR and associated PI 3 kinase. To determine the In the b receptor, mutation of tyrosine 1009 and 1021
extent of activation of PI 3 kinase by three PDGF iso- abolishes binding and activation of PLCg1 by PDGF BB
forms, we immunoprecipitated tyrosine phosphorylated [15]. In the a receptor, the homologous residues tyrosine
proteins from lysates of PDGF BB-, AB-, and AA- 988 and tyrosine 1018 have been identified as the binding
treated mesangial cells with antiphosphotyrosine anti- sites for PLCg1 [17]. It was shown that the complex
body. These immunoprecipitates were used for assay of between PLCg1 and a-receptor is more stable than that
PI 3 kinase activity. The results show significant activa- of b receptor and PLCg1, although a smaller fraction of
tion of PI 3 kinase by all three PDGF isoforms (Fig. 8). tyrosine phosphorylated PLCg1 was produced. Because
Activation of PI 3 kinase in response to the three iso- tyrosine phosphorylation of PLCg1 is required for its
forms was observed in a decreasing order: BB . AB . activity to hydrolyze PI 4,5-bisphosphate [38, 39], less
AA. These data indicate that, although PDGF AA fails tyrosine phosphorylation of PLCg1 resulted in a smaller
to induce DNA synthesis and migration in mesangial accumulation of inositol phosphates. We have also ob-
cells (Fig. 1), it significantly stimulates PI 3 kinase ac- served significant but less accumulation of inositol phos-
phates in mesangial cells in response to AA comparedtivity.
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Fig. 7. Association of PI 3 kinase activity
with a- and b-receptors. Mesangial cells were
incubated with either PDGF AA or AB. The
cleared cell lysates were immunoprecipitated
with a-receptor (A) and b-receptor (B) anti-
bodies (10 mg), respectively. The immunopre-
cipitates were used in PI 3 kinase assay as
described in the Methods section. The arrow
indicates PI-3-P spot.
with AB and BB (Fig. 4). Growth factors, including all strong chemotactic response, whereas PDGF AA does
not. In contrast, all three isoforms exhibit chemotaxisisoforms of PDGF, stimulate PI 3 kinase, the products
in granulocytes [31]. These data indicate that variousof which, the D3-phosphorylated inositides, have been
isotypes of PDGF induce different biological responsesimplicated in various biological responses in different
in an isoform– and cell-type–specific manner.cell types, including DNA synthesis and chemotaxis [40
Although the a receptor activates PI 3 kinase, thisand references therein]. Treatment of cells with PDGF
receptor stimulates migration in a cell-type specific man-results in the recruitment of this enzyme to tyrosine 7
ner. Thus, a-receptor–transfected 32 D cells, human[40] and 751 of the b receptor and tyrosine 731 and 742
granulocytes, and Swiss 3T3 cells expressing endogenousof the a receptor, respectively [13, 15]. Mutation of these
a-receptor show chemotaxis toward PDGF AA [31, 42,residues to phenylalanine in b receptor demonstrates
43]. We now demonstrate that in mesangial cells, AAimpaired binding and activation of PI 3 kinase, resulting
does not induce migration, although it causes a significantin inhibition of DNA synthesis and migration in response
increase in PI 3 kinase activity (Figs. 1, 5, and 7). It hasto PDGF [15, 36]. Using pharmacological inhibitors of
recently been reported that in porcine aortic endothelialthis enzyme, we have also recently shown the absolute
cells, the overexpression of a receptor does not allowrequirement of PI 3 kinase to regulate DNA synthesis
chemotaxis, whereas a point mutation of tyrosine 1018 toand migration in response to PDGF BB in mesangial
phenylalanine residue in this receptor restores migratorycells [20]. In the present study, we demonstrate that in
response [44]. Tyrosine 1018 is one of the autophosphor-spite of significant activation of PI 3 kinase in mesangial
ylation sites in this receptor. These data indicate thatcells by AA (Fig. 5 and Fig. 7), this PDGF isoform is
tyrosine 1018, when phosphorylated in response to AA,neither mitogenic nor chemotactic (Fig. 1).
negatively regulates migration of PDGF-stimulated cells.
The role of PI 3 kinase in PDGF-induced DNA synthe- It should be emphasized that tyrosine 1018 in the a
sis and migration is cell specific. For example, in FDCP2 receptor is the binding site for PLCg1 suggesting that,
myeloid progenitor cells, mutation of tyrosine 751 to similar to the b receptor, association of PLCg1 with a
phenylalanine in PDGFR-b, which impairs PI 3 kinase receptor is not necessary for chemotaxis. A corollary of
binding and DNA synthesis in other cell types, shows this observation is that association of PLCg1 to phospho-
pronounced DNA synthesis similar to wild-type receptor tyrosine at 1018 with concomitant tyrosine phosphoryla-
[16]. In vascular smooth muscle cells, inhibition of PI 3 tion and activation of its enzymatic activity, which pro-
kinase did not inhibit PDGF BB-induced chemotaxis, duces inositol phosphate and diacylglycerol, may inhibit
indicating that a PI 3 kinase-independent pathway exists chemotaxis. We demonstrated a significant increase in
[41]. In contrast, we have recently shown that inhibition the production of inositol phosphates in mesangial cells
of PI 3 kinase abolishes PDGF BB-induced migration in in response to AA (Fig. 4). These data indicate that
mesangial cells, indicating differences between vascular activation of PLCg1 possibly via its interaction with
smooth muscle cells and mesangial cells [20]. In fibro- a receptor may cause impaired migratory response to
AA in these cells (Fig. 1).blasts and monocytes, PDGF BB and PDGF AB induce
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